FcγR- and CD9-dependent synapse-engulfing microglia in the thalamus drive cognitive impairment following cortical

Ken Matoba1, Takahiro Kochi1,2, Oluwaseun Fatoba1

  • 1Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, USA.

Insights

Synapse-engulfing microglia in the thalamus, not the hippocampus, cause memory loss after brain damage. Blocking CD9 on these microglia restores memory, revealing a new therapeutic target for cognitive dysfunction.

Area of Science:

  • Neuroscience
  • Immunology

Background:

  • Chronic neuroinflammation involves diverse microglial states.
  • The role of region-specific microglial changes in cognitive dysfunction is not fully understood.

Purpose of the Study:

  • To investigate how region-specific microglial remodeling contributes to cognitive dysfunction after cortical brain damage.
  • To identify the mechanisms driving microglial changes and their impact on memory.

Main Methods:

  • Single-cell RNA sequencing to identify microglial subtypes.
  • Region-specific microglial manipulation in mice.
  • Antibody-based CD9 blockade and microglia-selective CD9 disruption.
  • Analysis of synaptic loss, neuronal activity, and recognition memory.

Main Results:

  • Synapse-engulfing CD9hi microglia are enriched in the thalamus and drive cognitive impairment.
  • Thalamic microglial changes, but not hippocampal ones, impair recognition memory.
  • CD9 blockade or disruption in the thalamus rescues synaptic loss and improves memory.
  • Blood-brain barrier disruption and IgG extravasation induce CD9hi microglia via FcγRIII signaling.

Conclusions:

  • Thalamic synapse-engulfing microglia mediate cognitive deficits post-cortical damage.
  • IgG/FcγRIII signaling drives the generation of these detrimental microglia.
  • Targeting CD9 in the thalamus offers a potential therapeutic strategy for memory recovery.

Related Concept Videos